TearExo Overview

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $347K

  • Investors
  • 14

TearExo General Information

Description

Developer of a research platform intended to detect cancer using human tears. The company's platform specializes in using tear fluid, which can be easily self-collected instead of blood, enabling researchers to reduce the time of specimen collection, lower the time and effort of making an appointment, and lower the examination hurdles.

Contact Information

Website
www.tearexo.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kobe University BMO Building, 1-1 Rokkodai-cho, Nada-ku
  • Kobe, Hyogo 657-8501
  • Japan
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Kobe University BMO Building, 1-1 Rokkodai-cho, Nada-ku
  • Kobe, Hyogo 657-8501
  • Japan

TearExo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TearExo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 14-May-2025 $347K Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
4. Seed Round 04-Aug-2023 Completed Generating Revenue
3. Accelerator/Incubator 16-Jan-2023 Completed Generating Revenue
2. Accelerator/Incubator 01-Aug-2022 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
To view TearExo’s complete valuation and funding history, request access »

TearExo Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B Preferred
A Preferred
To view TearExo’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TearExo Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

TearExo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024143431-A1 Sensor combined with particles Inactive 27-Dec-2022
WO-2024143430-A1 Sensor having vesicle template Inactive 27-Dec-2022
JP-2023182627-A Nanoparticle for sensing and method for producing the same Active 27-Feb-2020
JP-7799329-B2 Nanoparticles for sensing and their manufacturing method Active 27-Feb-2020
JP-7357975-B2 Sensing nanoparticles and their manufacturing method Active 27-Feb-2020 G01N33/54346
To view TearExo’s complete patent history, request access »

TearExo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TearExo Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
INDEE Capital Venture Capital Minority
Soken Chemical & Engineering Corporation Minority
Tech Planter Accelerator/Incubator
Chugin Capital Partner Venture Capital Minority
Japan Startup Support Association Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

TearExo FAQs

  • Where is TearExo headquartered?

    TearExo is headquartered in Kobe, Japan.

  • What is the size of TearExo?

    TearExo has 10 total employees.

  • What industry is TearExo in?

    TearExo’s primary industry is Decision/Risk Analysis.

  • Is TearExo a private or public company?

    TearExo is a Private company.

  • What is the current valuation of TearExo?

    The current valuation of TearExo is .

  • What is TearExo’s current revenue?

    The current revenue for TearExo is .

  • How much funding has TearExo raised over time?

    TearExo has raised $702K.

  • Who are TearExo’s investors?

    INDEE Capital, Soken Chemical & Engineering, Tech Planter, Chugin Capital Partner, and Japan Startup Support Association are 5 of 14 investors who have invested in TearExo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process